ESR1 and neoplasm: However, the influence of low-dose tamoxifen in preventing IBTR is similar to that of the RT in breast DCIS patients whose pathological tumor features are similar to the criteria of ECOG E5194 cohort 1 and have a positive ER status, but its effects remains uncertain.